{
  "id": 15719313,
  "title": "London’s Emerald secures €1.66 million to scale its preventive healthcare platform",
  "url": "https://urgent.news/2026/10/20/londons-emerald-secures-1-66-million-to-scale-its-preventive",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-20T08:03:45.000Z",
  "source": {
    "name": "EU-Startups",
    "slug": "eu-startups",
    "url": "https://www.eu-startups.com/2026/10/londons-emerald-secures-e1-66-million-to-scale-its-preventive-healthcare-platform/"
  },
  "original_language": "en",
  "account": "London-based preventive healthcare platform Emerald has secured £1.4 million ($1.85 million) in funding to expand its services. This brings the company's total funding to €3.44 million (£2.9 million) to date. The latest round includes an €832,200 grant from Innovate UK, its second award from the organization, and a €832,200 investment from venture capital firms. All existing investors joined new backers, including Sequel and Highgoal, in supporting the funding. Emerald's CEO, Alexander Badalyan, explained that there is significant demand for accessible healthcare tools that go beyond testing and provide actionable insight from trusted medical experts. The platform combines in-clinic laboratory screening with a digital system that combines results, wearable data, and health histories to help users identify potential health risks early. This approach is supported by a GP who can diagnose, prescribe, and refer patients to private and NHS care. Since launching in 2024, Emerald's member base has grown tenfold, processing over 100,000 laboratory tests and highlighting improvements in cholesterol, blood sugar, and inflammation levels. The company aims to become the UK's leading provider of long-term health management by leveraging its partnerships with businesses in employee benefits, FinTech, and fitness sectors. With the additional funding, Emerald plans to expand its AI capabilities to better personalize care for its one million planned members over the next three years.",
  "summary": "Emerald, a London-based preventive healthcare platform, has secured an additional €1.66 million (£1.4 million/$1.85 million) in funding. This brings the company’s total funding to date to €3.44 million (£2.9 million). The latest funding includes an €832.2k (£700k) grant from Innovate UK, Emerald’s second award from the organisation, together with a further €832.2k (£700k) in venture […] The post…",
  "key_points": [
    "London-based preventive healthcare platform Emerald secures €1.66 million in funding.",
    "Funding brings total to €3.44 million, supporting expansion of services.",
    "Platform combines in-clinic screening with digital system for early health risk identification."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}